Johnson & Johnson announced Tuesday that its sales and net earnings rose in the second quarter of 2014, and it raised its earnings guidance for the full year.
J&J said sales reached $19.5 billion for its Q2, up 9.1 percent from the second quarter of 2013, it said in a news release. In addition, net earnings reached $4.8 billion, or $1.66 per share, excluding special items. That was an increase of 11.3 percent and 12.2 percent, respectively, from the prior year.
"Our strong second-quarter results reflect the continued success of our new product launches and the progress we have made in achieving our near-term priorities," Alex Gorsky, chairman and CEO, said in the release. "Significant advancements are being made in the treatment options and access to care for patients and customers around the world. Our diversified business model, focus on long-term growth drivers and talented colleagues position us well in this evolving and dynamic global health care market."
J&J also said its full-year earnings would be $5.85 to $5.92 per share, excluding special items.
ALSO ON NJBIZ: